Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Nereus Pharmaceuticals initiates Phase II lung cancer trial
This study follows on positive outcomes in the Phase I study assessing the safety, pharmacokinetics and efficacy of the combination. The Phase II Advance trial will assess NPI-2358
This study follows on positive outcomes in the Phase I study assessing the safety, pharmacokinetics and efficacy of the combination. The Phase II Advance trial will assess NPI-2358
Under the terms of the agreement Merck will pay Xencor an upfront license fee of $3 million, and an additional payment upon selection of an Xtend variant. Merck
This follows the expiry of the agreement between the two companies under which Wyeth has held the marketing authorization for Prostap (leuprorelin acetate) from Takeda in the UK
Most recently, Ms Barrett held the position of vice president and general manager of oncology business unit at Cephalon. Ms Barrett’s previous oncology experience also includes managing Johnson
In her new capacity Ms Turso will be will be responsible for overseeing professional services, deployment, customer care, and product development. Ms Turso started her career at Air
Mr Rueckert is the managing member of Oyster Management Group, and is a director of Glycotex, an 83% owned unlisted subsidiary of Novogen. He was formerly a director
More specifically, VGX will design and test DNA vaccine candidates using target antigens from Plasmodium species and deliver them intradermally using the Cellectra constant current electroporation device. The
According to the company, the Jetstream G2 is a peripheral atherectomy catheter designed to remove all kinds of artery-clogging plaque in the lower limbs of patients. This minimally
Endo has acquired Indevus through a tender offer and subsequent merger upon which Indevus became a wholly owned subsidiary of Endo. The common stock of Indevus ceased trading
The complaint, which was filed in the US District Court of Delaware, alleges infringement of US patents, which expire on September 24, 2019, and another US patent which